Exploring the link between more negative osmotic potential and ryegrass summer performance

This paper outlines recent research studying within-population variation in selected New Zealand perennial ryegrass cultivars, for traits related to tolerance of summer moisture deficit. Two clonal replicates of 220 genotypes from ‘Grasslands Nui’ (Nui, n=50), ‘Grasslands Samson’ Samson, n=80), and ‘Trojan’ (n=90) were exposed to a 1 month of moisture deficit challenge, with plant water relations measurements performed to evaluate putative drought-response mechanisms. Water use of individual genotypes ranged from 1000 g water/g DM indicating large within-population variation for this trait. Mean WUE for Nui, Samson, and Trojan was, respectively, 424±16, 412±10, and 319±9 g water/g DW (P<0.001), suggesting that commercial plant breeding may have indirectly reduced water use in modern cultivars without specific focus on water relations. Principal component analysis indicated more negative osmotic potential may contribute to reduced water use while maintaining yield under water deficit, giving a potential focus for future breeding selection targeting summer water deficit tolerance.fals

European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment.

AIMS: To develop quality indicators (QIs) for the evaluation of the prevention and management of cancer therapy-related cardiovascular toxicity. METHODS AND RESULTS: We followed the European Society of Cardiology (ESC) methodology for QI development which comprises (i) identifying the key domains of care for the prevention and management of cancer therapy-related cardiovascular toxicity in patients on cancer treatment, (ii) performing a systematic review of the literature to develop candidate QIs, and (iii) selecting of the final set of QIs using a modified Delphi process. Work was undertaken in parallel with the writing of the 2022 ESC Guidelines on Cardio-Oncology and in collaboration with the European Haematology Association, the European Society for Therapeutic Radiology and Oncology and the International Cardio-Oncology Society. In total, 5 main and 9 secondary QIs were selected across five domains of care: (i) Structural framework, (ii) Baseline cardiovascular risk assessment, (iii) Cancer therapy related cardiovascular toxicity, (iv) Predictors of outcomes, and (v) Monitoring of cardiovascular complications during cancer therapy. CONCLUSION: We present the ESC Cardio-Oncology QIs with their development process and provide an overview of the scientific rationale for their selection. These indicators are aimed at quantifying and improving the adherence to guideline-recommended clinical practice and improving patient outcomes

European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment.

AIMS: To develop quality indicators (QIs) for the evaluation of the prevention and management of cancer therapy-related cardiovascular toxicity. METHODS AND RESULTS: We followed the European Society of Cardiology (ESC) methodology for QI development which comprises (i) identifying the key domains of care for the prevention and management of cancer therapy-related cardiovascular toxicity in patients on cancer treatment, (ii) performing a systematic review of the literature to develop candidate QIs, and (iii) selecting of the final set of QIs using a modified Delphi process. Work was undertaken in parallel with the writing of the 2022 ESC Guidelines on Cardio-Oncology and in collaboration with the European Haematology Association, the European Society for Therapeutic Radiology and Oncology and the International Cardio-Oncology Society. In total, 5 main and 9 secondary QIs were selected across five domains of care: (i) Structural framework, (ii) Baseline cardiovascular risk assessment, (iii) Cancer therapy related cardiovascular toxicity, (iv) Predictors of outcomes, and (v) Monitoring of cardiovascular complications during cancer therapy. CONCLUSION: We present the ESC Cardio-Oncology QIs with their development process and provide an overview of the scientific rationale for their selection. These indicators are aimed at quantifying and improving the adherence to guideline-recommended clinical practice and improving patient outcomes

Higgs boson decay into 2 photons in the type~II Seesaw Model

We study the two photon decay channel of the Standard Model-like component of the CP-even Higgs bosons present in the type II Seesaw Model. The corresponding cross-section is found to be significantly enhanced in parts of the parameter space, due to the (doubly-)charged Higgs bosons' $(H^{\pm \pm})H^\pm$ virtual contributions, while all the other Higgs decay channels remain Standard Model(SM)-like. In other parts of the parameter space $H^{\pm \pm}$ (and $H^{\pm}$) interfere destructively, reducing the two photon branching ratio tremendously below the SM prediction. Such properties allow to account for any excess such as the one reported by ATLAS/CMS at $\approx 125$ GeV if confirmed by future data; if not, for the fact that a SM-like Higgs exclusion in the diphoton channel around 114-115 GeV as reported by ATLAS, does not contradict a SM-like Higgs at LEP(!), and at any rate, for the fact that ATLAS/CMS exclusion limits put stringent lower bounds on the $H^{\pm \pm}$ mass, particularly in the parameter space regions where the direct limits from same-sign leptonic decays of $H^{\pm \pm}$ do not apply.Comment: 26 pages, 7 figure

Low-mass fermiophobic charged Higgs phenomenology in two-Higgs-doublet models

After the recent discovery of a Higgs-like boson, the possibility of an enlarged scalar sector arises as a natural question. Experimental searches for charged scalars have been already performed with negative results. We analyze the phenomenology associated with a fermiophobic charged Higgs (it does not couple to fermions at tree level), in two-Higgs-doublet models. All present experimental bounds are evaded trivially in this case, and one needs to consider other decay and production channels. We study the associated production of a charged Higgs with either a W or a neutral scalar boson, and the relevant decays for a light fermiophobic charged Higgs. The interesting features of this scenario should result encouraging for the LHC collaborations to perform searches for such a particle

Dephosphorylated NSSR1 Is Induced by Androgen in Mouse Epididymis and Phosphorylated NSSR1 Is Increased during Sperm Maturation

NSSR1 (Neural salient serine/arginine rich protein 1, alternatively SRp38) is a newly identified RNA splicing factor and predominantly expressed in neural tissues. Here, by Western blot analysis and immunofluorescent staining, we showed that the expression of dephosphorylated NSSR1 increased significantly during development of the caput epididymis. In adult mice, phosphorylated NSSR1 was mainly expressed in the apical side of epithelial cells, and dephosphorylated NSSR1 in caput epididymis was upregulated in a testosterone dependent manner. In addition, subcellular immunoreactive distribution of NSSR1 varied in different regions of the epididymis. With respect to the sperm, phosphorylated NSSR1 was detected in the mid-piece of the tail as well as the acrosome. Furthermore, NSSR1 was released from the sperm head during the capacitation and acrosome reaction. These findings for the first time provide the evidence for the potential roles of NSSR1 in sperm maturation and fertilization

Endomyocardial Fibrosis: Still a Mystery after 60 Years

The pathologist Jack N. P. Davies identified endomyocardial fibrosis in Uganda in 1947. Since that time, reports of this restrictive cardiomyopathy have come from other parts of tropical Africa, South Asia, and South America. In Kampala, the disease accounts for 20% of heart disease patients referred for echocardiography. We conducted a systematic review of research on the epidemiology and etiology of endomyocardial fibrosis. We relied primarily on articles in the MEDLINE database with either “endomyocardial fibrosis” or “endomyocardial sclerosis” in the title. The volume of publications on endomyocardial fibrosis has declined since the 1980s. Despite several hypotheses regarding cause, no account of the etiology of this disease has yet fully explained its unique geographical distribution

PhagoSight: an open-source MATLAB® package for the analysis of fluorescent neutrophil and macrophage migration in a zebrafish model

Neutrophil migration in zebrafish larvae is increasingly used as a model to study the response of these leukocytes to different determinants of the cellular inflammatory response. However, it remains challenging to extract comprehensive information describing the behaviour of neutrophils from the multi-dimensional data sets acquired with widefield or confocal microscopes. Here, we describe PhagoSight, an open-source software package for the segmentation, tracking and visualisation of migrating phagocytes in three dimensions. The algorithms in PhagoSight extract a large number of measurements that summarise the behaviour of neutrophils, but that could potentially be applied to any moving fluorescent cells. To derive a useful panel of variables quantifying aspects of neutrophil migratory behaviour, and to demonstrate the utility of PhagoSight, we evaluated changes in the volume of migrating neutrophils. Cell volume increased as neutrophils migrated towards the wound region of injured zebrafish. PhagoSight is openly available as MATLAB® m-files under the GNU General Public License. Synthetic data sets and a comprehensive user manual are available from http://www.phagosight.org